Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nasal endoscopy topical anaesthesia comparison
ACTRN12622001146785Phase 3Terminated
- Sponsor
- The University of Auckland
- Start
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of tetracaine, oxymetazoline, lidocaine and phenylephrine, sponsored by The University of Auckland. Primary endpoints: Difference in subjectively reported comfort of nasal endoscopy between sides and Local anaesthetic systemic toxicity. Started May 2023; status: terminated.
02
Drugs
tetracaineoxymetazolinelidocainephenylephrine
Beyond the preview
Go deeper on ACTRN12622001146785.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12622001146785.